Coronavirus NL63 Nucleic Acid Detection Kit (PCR-Fluorescence)

A diagnostic test kit for the detection of SARS-CoV-2 (2019-nCoV) nucleic acids using fluorescence PCR methodology. The kit is designed for COVID-19 diagnostic testing.

A diagnostic test kit for the simultaneous detection of SARS-CoV-2 and influenza A and B virus nucleic acids using fluorescence PCR methodology. The kit enables multiplex detection of COVID-19 and influenza in a single assay.

This product is used for in vitro qualitative detection of Nipah virus nucleic acid in oropharyngeal swabs, nasopharyngeal swabs, cerebrospinal fluid, serum, and urine samples.

CLIA-waived fluorescence PCR detection kit for rapid SARS-CoV-2 identification. The AccuFluor platform delivers real-time PCR results for COVID-19 diagnosis with 510(k) clearance, enabling healthcare facilities to quickly screen patients and guide clinical management decisions.

A diagnostic test kit for the detection of influenza A and B virus nucleic acids using fluorescence PCR methodology. The kit is designed for rapid identification of influenza virus infections.

CLIA-waived PCR detection kit for simultaneous identification of SARS-CoV-2 and Influenza A/B using direct fluorescence technology. Enables rapid respiratory pathogen screening in clinical and point-of-care settings with streamlined sample-to-result workflow.

Real-time fluorescence PCR kit for detection of Neisseria gonorrhoeae nucleic acids in clinical specimens. Provides sensitive molecular confirmation of gonococcal infection.

A reagent kit formulated for use with real-time quantitative PCR instruments in molecular diagnostics. The kit supports gene detection and microbial identification in clinical and research settings.

A diagnostic test kit for detecting Aspergillus nucleic acid using fluorescence polymerase chain reaction method.

A diagnostic test kit for the simultaneous detection of respiratory syncytial virus and Mycoplasma pneumoniae nucleic acids using fluorescence PCR methodology.

This product is intended for in vitro qualitative detection of nucleic acid from Bundybugyo Ebola Virus in human whole blood, serum/plasma, and oral swab samples.

Fluorescence PCR-based detection kit for rapid identification of Influenza A and B viruses in clinical specimens. Designed for molecular diagnostics in laboratory settings with high sensitivity and specificity for influenza virus screening and confirmation.